Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Transcutaneous Spinal Cord Stimulation for Motor Recovery After Spinal Cord Injury

13 novembre 2026 mis à jour par: Dr. Gabriel Zeilig

Restoring Upper and Lower Extremity Functions in Persons With Spinal Cord Injury by Transcutaneous Spinal Cord Stimulation

This study will examine the safety, feasibility, and potential benefits of transcutaneous spinal cord stimulation (scTS) combined with activity-based training in people with spinal cord injury.

The study will include 10 adults with chronic, incomplete spinal cord injury. Electrical stimulation will be delivered through electrodes placed on the skin over different regions of the spinal cord, while participants perform exercises involving the arms, hands, trunk, and legs.

Participants will undergo initial assessments, individualized stimulation mapping, and 80 training sessions, followed by final assessments. Researchers will evaluate changes in motor function, muscle activity, psychological well-being, autonomic function, and quality of life. Safety and tolerability will also be monitored throughout the study.

Aperçu de l'étude

Description détaillée

This prospective, single-arm, within-subject exploratory study will enroll 10 adults aged 18-65 years with chronic incomplete cervical or thoracic spinal cord injury.

The study includes four phases: (1) baseline assessments over approximately two months; (2) stimulation mapping and optimization over approximately 0.5-1 month to identify individualized stimulation parameters; (3) 80 sessions of multisegment transcutaneous spinal cord stimulation combined with activity-based training, delivered 3-5 days per week over approximately 4-7 months; and (4) follow-up assessments.

The intervention targets upper and lower extremity function, trunk control, standing, and stepping. Motor performance will be assessed primarily using the Neuromuscular Recovery Scale (NRS). Additional assessments will examine muscle activation using electromyography (EMG), psychological symptoms, autonomic function, neurological status, spasticity, functional independence, and quality of life.

Intermediate assessments will be conducted during the intervention, including after 40 training sessions. Safety, adverse events, and feasibility will be evaluated throughout the study.

Type d'étude

Interventionnel

Inscription (Estimé)

10

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

      • Ramat Gan, Israël
        • Sheba Medical Center
        • Contact:
        • Sous-enquêteur:
          • Einat Haber, M.D.

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 65 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  1. At least 18 years of age.
  2. Non-progressive cervical or thoracic (>T10) spinal cord injury (SCI), with the ability to voluntarily move at least three joints below the injury level.
  3. At least 6 months post spinal cord injury.
  4. Stable medical condition.
  5. Neuromuscular Recovery Scale (NRS) score <4C on any upper extremity, trunk, or standing/stepping item.

Exclusion Criteria:

  1. Ventilator dependence.
  2. Untreated or unstable fracture or pressure ulcer.
  3. Untreated psychiatric disorder or ongoing drug abuse.
  4. Cardiac, respiratory, bladder, renal, or other medical disorder that may interfere with the study.
  5. Skeletal muscle Botox injections within the previous 6 months.
  6. Previous nerve or tendon transfer of the arms or legs.
  7. Any implanted pump (e.g., baclofen pump or pain pump).
  8. Unable or unwilling to discontinue anti-spasticity medications.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Multisegment scTS + Activity-Based Training

Participants will receive individualized multisegment transcutaneous spinal cord stimulation (scTS) combined with activity-based training targeting upper and lower extremity function, trunk control, standing, and stepping. The intervention will consist of 80 training sessions, delivered 3-5 days per week over approximately 4-7 months, with sessions lasting up to 2 hours.

Non-invasive electrical stimulation delivered through surface electrodes placed over multiple spinal levels using the NeoStim-5 system. Stimulation sites and parameters will be individually optimized to facilitate motor activation of the upper extremities, trunk, and lower extremities during activity-based training.

Individualized, task-specific rehabilitation training targeting voluntary control of the hands, arms, trunk, and legs, including seated activities, standing, and stepping. Training will be provided by rehabilitation staff and combined with transcutaneous spinal cord stimulation.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Motor Function (NRS)
Délai: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in motor performance assessed using the Neuromuscular Recovery Scale (NRS), which evaluates movement quality and the level of assistance required during upper extremity, trunk, standing, and stepping tasks. Changes in individual task ratings will be assessed across study time points.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Safety
Délai: From enrollment through the final study assessment (approximately 7-10 months per participant).

Incidence of adverse events and equipment-related complications during the study. Adverse events will be categorized by severity, relatedness to study procedures, and expectedness.

From enrollment through the final study assessment (approximately 7-10 months per participant).

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in Surface EMG Amplitude During Functional Motor Tasks
Délai: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in surface electromyography (EMG) signal amplitude during functional motor tasks involving upper extremity, trunk, and lower extremity muscles.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Depression (PHQ-9)
Délai: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Anxiety (GAD-7)
Délai: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in anxiety symptoms measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
PTSD (PCL-5)
Délai: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)

Changes in self-reported post-traumatic stress symptoms measured using the PTSD Checklist for DSM-5 (PCL-5). Total scores range from 0 to 80, with higher scores indicating greater symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training)
PTSD (CAPS-5)
Délai: Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).

Changes in clinician-rated post-traumatic stress symptom severity measured using the CAPS-5. The total severity score ranges from 0 to 80, with higher scores indicating greater symptom severity.

Baseline, after 40 training sessions, and after 80 training sessions (approximately 4-7 months of training).
Change in ISNCSCI Total Motor Score
Délai: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in motor function assessed using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). The total motor score ranges from 0 to 100, with higher scores indicating better motor function.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Modified Ashworth Scale (MAS) Score
Délai: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in muscle spasticity assessed by a clinician using the Modified Ashworth Scale, which grades resistance to passive movement.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) Score
Délai: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in the self-reported impact of spasticity on daily activities, assessed using the SCI-SET questionnaire covering the preceding seven days.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) Questionnaire Score
Délai: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in frequency and severity of symptoms associated with blood pressure instability, assessed using the 24-item ADFSCI questionnaire.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Modified Functional Reach Test Distance
Délai: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in maximum forward reaching distance while seated, measured using the Modified Functional Reach Test

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)
Change in Activity-Based Balance Level (ABLE) Sitting Subscale Score
Délai: Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Change in sitting balance assessed using the seven items of the ABLE sitting subscale, with a maximum score of 32.

Baseline and post-training assessment (after 80 training sessions; approximately 4-7 months of training)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 janvier 2027

Achèvement primaire (Estimé)

1 janvier 2029

Achèvement de l'étude (Estimé)

1 janvier 2030

Dates d'inscription aux études

Première soumission

8 novembre 2026

Première soumission répondant aux critères de contrôle qualité

13 novembre 2026

Première publication (Réel)

16 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

16 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner